Tarsus to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Tarsus (NASDAQ: TARS) announced management will participate in three investor conferences in May 2026: Bank of America Health Care Conference on May 12 (3:40 p.m. PT / 6:40 p.m. ET), H.C. Wainwright BioConnect on May 19 (8:00 a.m. PT / 11:00 a.m. ET), and Stifel Virtual Ophthalmology Forum on May 26 (12:30 p.m. PT / 3:30 p.m. ET).

Live webcasts and additional details are available on the company's events page. Replays will be posted within 48 hours and archived for a limited time.

News Market Reaction – TARS

-4.30%

9 alerts

-4.30% Session close to close

-3.7% Trough in 2 min

$2.64B Market Cap

0.5x Rel. Volume

In the May 8 session, TARS declined 4.30%, reflecting a moderate negative market reaction. Argus tracked a trough of -3.7% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

IRVINE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences:

• Bank of America Securities 2026 Health Care Conference on Tuesday, May 12^th, at 3:40 p.m. PT / 6:40 p.m. ET.
• H.C. Wainwright 4^th Annual BioConnect Investor Conference at NASDAQ on Tuesday, May 19^th, at 8:00 a.m. PT / 11:00 a.m. ET.
• Stifel 2026 Virtual Ophthalmology Forum on Tuesday, May 26^th, at 12:30 p.m. PT / 3:30 p.m. ET.
  
  

Live webcasts and additional information can be accessed on the events section of the Tarsus website. Replays will be available on the Tarsus website within 48 hours and will be archived for a limited time.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY^® (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 as an ophthalmic gel for the potential treatment of ocular rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease, both of which are in Phase 2.

Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com

FAQ

When will TARS present at the Bank of America Health Care Conference in May 2026?

Tarsus will present at 3:40 p.m. PT / 6:40 p.m. ET on May 12, 2026. According to the company, the event will be webcast live and details are posted on the company's events page for investors and media access.

How can investors watch TARS presentations at the H.C. Wainwright BioConnect conference on May 19, 2026?

Investors can watch the presentation via a live webcast on the company's events page. According to the company, replays will be available within 48 hours and archived for a limited time for later viewing.

What time is the Tarsus management session at the Stifel 2026 Virtual Ophthalmology Forum on May 26?

The session is scheduled for 12:30 p.m. PT / 3:30 p.m. ET on May 26, 2026. According to the company, the presentation will be webcast live and the replay posted on the events section of the website.

Will TARS make replays of its May 2026 investor presentations available online?

Yes, replays will be posted within 48 hours after each presentation and archived for a limited time. According to the company, replays and related materials will be accessible on the company's events webpage.

Where can shareholders find more details and timing for TARS investor conferences in May 2026?

Shareholders can find schedules, webcast links, and replay availability on the company's events page. According to the company, all webcast information and timing details for the May conferences are posted there.